Literature DB >> 8095909

Cleavage of human MDR1 mRNA by a hammerhead ribozyme.

H Kobayashi1, T Dorai, J F Holland, T Ohnuma.   

Abstract

We designed a hammerhead ribozyme which site-specifically cleaved the GUC sequence in codon 179 of MDR1 mRNA. The cleavage site was 6 amino acids upstream from the drug binding site and was considered sufficiently close to the essential locus for P-glycoprotein function. The ribozyme cleaved the MDR1 mRNA under physiological conditions in vitro. The cleavage was dependent on ribozyme concentration and on incubation time. Mg2+ ion was essential for the cleavage. These results show that a potentially useful tool is at hand which may inactivate MDR1 mRNA and revert the multidrug resistance phenotype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095909     DOI: 10.1016/0014-5793(93)80039-w

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies.

Authors:  Chung-Pu Wu; Anna Maria Calcagno; Suresh V Ambudkar
Journal:  Curr Mol Pharmacol       Date:  2008-06       Impact factor: 3.339

Review 2.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

3.  RNases involved in ribozyme degradation in Escherichia coli.

Authors:  J Y Wang; L Qiu; E D Wu; K Drlica
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490

4.  Inhibition of MDR1 gene expression by chimeric HNA antisense oligonucleotides.

Authors:  Hyunmin Kang; Michael H Fisher; Dong Xu; Yuko J Miyamoto; Arnaud Marchand; Arthur Van Aerschot; Piet Herdewijn; Rudolph L Juliano
Journal:  Nucleic Acids Res       Date:  2004-08-17       Impact factor: 16.971

Review 5.  P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells.

Authors:  T Licht; I Pastan; M Gottesman; F Herrmann
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

6.  Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance.

Authors:  D Byrne; C Daly; R Nicamhlaoibh; A Howlett; K Scanlon; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

7.  Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells.

Authors:  M Kiehntopf; M A Brach; T Licht; S Petschauer; L Karawajew; C Kirschning; F Herrmann
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

8.  Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.

Authors:  E W Eijdems; G J Zaman; M de Haas; C H Versantvoort; M J Flens; R J Scheper; E Kamst; P Borst; F Baas
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

9.  Analysis of Candidate Idarubicin Drug Resistance Genes in MOLT-3 Cells Using Exome Nuclear DNA.

Authors:  Tomoyoshi Komiyama; Atsushi Ogura; Takehito Kajiwara; Yoshinori Okada; Hiroyuki Kobayashi
Journal:  Genes (Basel)       Date:  2018-08-01       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.